How Much Tumor Is Enough to Leave Behind? Volumetric Study Redefines Craniopharyngioma Surgery Risk

Craniopharyngiomas are among the most deceptively complicated tumors in neurosurgery. Though histologically benign, these epithelial lesions arising near the pituitary gland and optic chiasm sit in some of the most functionally crowded real estate in the human brain, wedged against structures that govern vision, hormone regulation, memory, and appetite. For decades, surgeons have debated a deceptively simple question: how much tumor must be removed to keep it from coming back? A new volumetric analysis published in the Journal of Neuro-Oncology by researchers at the Sri Sathya Sai Institute of Higher Medical Sciences in Bengaluru, India, offers one of the most quantitative answers to date, and its findings suggest that the answer may be measured not just in percentages of resection, but in cubic centimeters of residual tissue.

The study, led by Sauradeep Sarkar and colleagues, retrospectively analyzed 60 patients with adamantinomatous craniopharyngioma, the most common histological subtype in children and young adults. Crucially, none of the patients received planned adjuvant radiotherapy after surgery, which allowed the researchers to isolate the effect of surgery itself on tumor control. Using manual segmentation of preoperative and postoperative magnetic resonance imaging scans, the team calculated precise tumor volumes and derived the extent of resection, or EOR, for each patient. With a median follow-up of five years, the dataset provided a robust window into how surgical decisions made in the operating room play out over the years that follow.

The headline finding is sobering: tumor progression or recurrence occurred in 60 percent of patients during follow-up. That figure underscores why the craniopharyngioma debate remains so heated. These tumors have a notorious tendency to regrow, and the surgical community remains split between advocates of aggressive gross-total resection, which maximizes tumor control but risks damage to the hypothalamus, optic pathways, and pituitary stalk, and proponents of conservative surgery followed by radiation, which spares critical structures but exposes patients to the long-term costs of irradiating a developing or aging brain.

On univariable analysis, the researchers found that each 1 percent increase in extent of resection was associated with a modest but statistically significant improvement in progression-free survival, with a hazard ratio of 0.981. In practical terms, the more completely the tumor was removed, the longer patients remained free of recurrence. But the analysis went further than the traditional binary of gross-total versus subtotal resection. Each additional cubic centimeter of residual solid tumor increased the risk of progression by a hazard ratio of 1.178, meaning that even small volumes of leftover solid disease carried measurable consequences. Preoperative tumor volume itself also mattered, with each additional cubic centimeter of starting tumor nudging the hazard ratio upward by 1.006.

Perhaps the most striking result concerned cystic disease. Patients left with residual cystic components after surgery faced more than three and a half times the risk of progression compared with those who did not, with a hazard ratio of 3.600. This finding aligns with a growing body of literature on the biology of adamantinomatous craniopharyngioma, which is characterized by finger-like protrusions of tumor into surrounding brain tissue and by cyst walls that harbor proliferative epithelial cells capable of independent growth. Cysts are not merely fluid-filled spaces to be drained; their walls can be biologically active, and leaving them behind appears to be a potent predictor of future trouble.

Because extent of resection and residual solid tumor volume are mathematically intertwined, the researchers constructed separate multivariable models to avoid the statistical distortion caused by collinearity. In both models, the volumetric variables retained their significance, and residual cystic disease remained a strong independent predictor of progression regardless of which model was used. This methodological care matters. Many prior studies have relied on the surgeon’s operative impression of whether resection was total or subtotal, a subjective judgment that can diverge substantially from what postoperative imaging actually shows. By quantifying residual disease in cubic centimeters, the Bengaluru team converted a binary surgical judgment into a continuous, gradable risk variable.

The predictive power of these volumetric measures was assessed using time-dependent receiver operating characteristic analysis at three years, a technique that evaluates how well a model discriminates between patients who progress and those who remain disease-free at a specific time point. The optimism-corrected area under the curve was 0.777 for the extent-of-resection model and 0.813 for the residual solid tumor volume model. Values above 0.8 are generally considered to indicate good discriminative ability, suggesting that simple measurements from routine postoperative MRI could meaningfully stratify patients into higher- and lower-risk groups without requiring any additional testing.

The clinical implications of this risk stratification are substantial. The current standard of care after incomplete craniopharyngioma resection is often immediate adjuvant radiotherapy, which improves tumor control but carries well-documented long-term risks including hypothalamic dysfunction, vascular injury, cognitive effects, and secondary tumors, particularly in children. Conversely, a surveillance strategy spares patients these risks but requires vigilant imaging and readiness to intervene at the first sign of progression. The Bengaluru group’s own prior work has compared upfront irradiation with postoperative surveillance after incomplete resection, and the new volumetric data provide a quantitative framework for making that choice patient by patient. A patient with a near-complete resection, minimal residual solid disease, and no residual cyst might reasonably be monitored with serial MRI, while a patient with several cubic centimeters of residual solid tumor or a residual cystic component might be steered toward earlier radiotherapy.

The study also resonates with parallel developments in the field. The Response Assessment in Pediatric Neuro-Oncology Working Group has emphasized standardized volumetric response assessment for craniopharyngioma, and proton beam therapy centers have documented the importance of tracking cyst dynamics during treatment. Recent surgical series have explored two-stage strategies for cystic tumors and examined the prognostic significance of the tumor’s microscopic finger-like protrusions, which can extend beyond what is visible on even high-resolution MRI. Together, these strands of evidence point toward a common conclusion: craniopharyngioma management is moving away from one-size-fits-all paradigms and toward precision approaches in which imaging-derived measurements directly inform treatment intensity.

Limitations remain, as they do in any retrospective single-institution analysis. Manual segmentation is labor-intensive and subject to interobserver variability, and the cohort of 60 patients, while carefully followed, cannot capture the full heterogeneity of craniopharyngioma presentations, including the giant tumors that pose distinct surgical challenges. The authors note that the underlying data are sensitive and available only upon reasonable request. Nevertheless, the core message is difficult to ignore: the fate of a patient with craniopharyngioma is written, at least in part, in the cubic centimeters of tumor left behind, and especially in whether any of what remains is cystic. As neurosurgeons continue to balance the competing imperatives of tumor control and quality of life, volumetric analysis offers a common language for that negotiation, one that could transform the postoperative conversation from a matter of surgical philosophy into a matter of measurable risk.

Subject of Research: Volumetric determinants of progression-free survival after craniopharyngioma resection

Article Title: Extent of resection and craniopharyngioma recurrence: a volumetric analysis

Article References: Sarkar, S., Vijayaraghavan, S., Thakar, S., & Aryan, S. (2026). Extent of resection and craniopharyngioma recurrence: a volumetric analysis. Journal of Neuro-Oncology, 179(2), Article 65. https://doi.org/10.1007/s11060-026-05770-6

Image Credits: AI Generated

DOI: 10.1007/s11060-026-05770-6

Keywords: craniopharyngioma, extent of resection, tumor volumetry, progression-free survival, residual cystic disease, neurosurgery, MRI segmentation, Cox regression, adjuvant radiotherapy, adamantinomatous craniopharyngioma, Journal of Neuro-Oncology, risk stratification